- 1What Is Alpha 1-Antitrypsin Deficiency Seen in Your Children?
- 2How Can Your Child Get Affected?
- 3What Are the Causes of Alpha-1 Antitrypsin Deficiency Seen in Children?
- 4What Are the Symptoms of Alpha-1 Antitrypsin Deficiency?
- 5How Is Alpha-1 Antitrypsin Deficiency Diagnosed?
- 6How Is Alpha-1 Antitrypsin Deficiency Managed in Children?
- 7What Are the Risk Factors of Alpha-1 Antitrypsin Deficiency in Children?
- 8What Are the Long-Term Effects of Alpha-1 Antitrypsin Deficiency in Children?
- 9What Is the Prognosis for Pediatric Patients With AATD-Related Liver Disease?
- 10What Are the Alpha-1-Related Research Studies & Clinical Trials?
Introduction
Alpha-1 antitrypsin deficiency (AATD) in children causes damage to the liver or lungs, which can be a genetic condition. This change results in an abnormal type of protein known as alpha-1 antitrypsin. The main function of alpha-1 antitrypsin is to protect the body from a powerful enzyme made by white blood cells. This enzyme is not controlled in those with alpha-1 antitrypsin deficiency. Some patients with alpha-1 antitrypsin deficiency may also have liver disease and can have symptoms like a swollen abdomen, feet, or legs and yellowing of the skin or eyes. Currently, there is no prevention for alpha-1 antitrypsin deficiency.
What Is Alpha 1-Antitrypsin Deficiency Seen in Your Children?
AATD in children is a genetic condition that attacks the lungs and liver. Changes are seen in the gene that produces alpha-1 antitrypsin protein, which helps to protect the liver and lung damage.
How Can Your Child Get Affected?
Alpha-1 antitrypsin deficiency runs in families. It cannot be prevented. It does not show a specific difference for any gender, race, or ethnicity. However, it is more commonly seen in white populations in North-European areas. Each individual inherits two AAT (alpha-1 antitrypsin) genes, one from each parent. Sometimes, a child carries one normal AAT gene from one parent and an abnormal AAT gene from another parent, making them a carrier of the condition. These children may have lower levels of AAT protein; however, they may not suffer from AAT deficiency. However, they can pass these altered genes to their children.
What Are the Causes of Alpha-1 Antitrypsin Deficiency Seen in Children?
Mutation seen in a SERPANI1 gene causes alpha-1 antitrypsin deficiency. This results in a reduced or abnormal form of protein known as alpha-1 antitrypsin. This protein protects the body from an enzyme produced by the white blood cells known as neutrophil elastase. The function of this enzyme is to fight against infections. However, in case of alpha-1 antitrypsin deficiency condition this enzyme is not controlled and can result in lung damage.
What Are the Symptoms of Alpha-1 Antitrypsin Deficiency?
The following are alpha-1 antitrypsin deficiency child symptoms,
-
Jaundice is characterized by the yellow appearance of the skin and the sclera at birth.
-
White and pale stools that are foul-smelling.
-
A long-term liver condition where the scar tissue replaces the liver tissue.
-
Reduced weight gain.
-
Reduced speed of eating.
-
Nausea and vomiting.
-
Backward flow of acid back into the esophagus.
-
Problems related to nursing.
-
Loss of appetite.
-
Enlarged spleen or abdomen.
-
Reduced or no energy.
How Is Alpha-1 Antitrypsin Deficiency Diagnosed?
Alpha-1 antitrypsin deficiency can be difficult to diagnose. No physical and early signs and symptoms can be used to confirm the diagnosis. Some investigations and blood tests may provide more clarity. Some of the methods are mentioned below:
-
General examination using X-rays or listening for abnormal sounds with a stethoscope can identify breathing problems in patients. This helps confirm the diagnosis.
-
Genetic tests showing a mutation in the SERPINA1 gene can confirm the presence of alpha-1 antitrypsin deficiency.
-
Blood tests can be done to see the level of alpha-1 antitrypsin in the blood. Low levels may indicate alpha-1 antitrypsin deficiency.
How Is Alpha-1 Antitrypsin Deficiency Managed in Children?
No specific cure is available to treat alpha-1 antitrypsin deficiency. However, various measures can be taken to manage the symptoms of this condition, as stated below:
-
Alpha-1 antitrypsin protein.
-
Transplantation of the liver.
-
Avoid irritants such as smoking, avoiding dust particles, fumes, etc.
-
Antibiotics can be used to treat respiratory tract infections.
-
Use of bronchodilators.
What Are the Risk Factors of Alpha-1 Antitrypsin Deficiency in Children?
Alpha-1 antitrypsin deficiency is developed through an altered SERPINA1 gene. An individual generally has two copies of the SERPINA1 gene. Having just one mutated copy of the SERPINA1 gene poses a low possibility. But, having two mutated copies of SERPINA1 increases the probability of the condition. Therefore, a couple with each parent carrying a mutated SERPINA1 gene is at a higher risk. Where the child may be affected by alpha-1 antitrypsin deficiency, as each of them can pass a mutated copy of the SERPINA1 gene. In some cases, the altered SERPINA1 gene may be less severe compared to others. This results in a slightly reduced ability of the gene to function properly. Individuals carrying these less severe altered genes of SERPINA1 have a lower chance of passing the disease to their children.
What Are the Long-Term Effects of Alpha-1 Antitrypsin Deficiency in Children?
Alpha-1 antitrypsin deficiency can result in long-term effects like liver damage, lung damage, and reduced life expectancy.
What Is the Prognosis for Pediatric Patients With AATD-Related Liver Disease?
The course of this condition can vary widely, with some self-limiting liver conditions seen in children. However, many people may develop severe liver disease, which leads to liver transplant. A good prognosis is seen in early diagnosis and management.
What Are the Alpha-1-Related Research Studies & Clinical Trials?
Research on alpha-1 has resulted in breakthroughs for more than 20 years. Based on the child’s condition, they may be eligible for clinical trials. Research is carried out to investigate new treatments for AATD.
Conclusion
Alpha-1 antitrypsin deficiency cannot be prevented as it is inborn and passes through families. Currently, there is no cure for this condition, however, the symptoms caused by the condition can be managed. If any symptoms related to this condition occur or alpha-1 antitrypsin deficiency is seen in a child, it is essential to consult a physician.